1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.06%
Positive revenue growth while WEED.TO is negative. John Neff might see a notable competitive edge here.
127.38%
Positive gross profit growth while WEED.TO is negative. John Neff would see a clear operational edge over the competitor.
38.32%
Positive EBIT growth while WEED.TO is negative. John Neff might see a substantial edge in operational management.
38.32%
Operating income growth above 1.5x WEED.TO's 23.31%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
65.75%
Positive net income growth while WEED.TO is negative. John Neff might see a big relative performance advantage.
66.67%
Positive EPS growth while WEED.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
66.67%
Positive diluted EPS growth while WEED.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
5.20%
Share reduction more than 1.5x WEED.TO's 40.11%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
5.20%
Diluted share reduction more than 1.5x WEED.TO's 40.11%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
293.60%
Positive OCF growth while WEED.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
184.22%
Positive FCF growth while WEED.TO is negative. John Neff would see a strong competitive edge in net cash generation.
No Data
No Data available this quarter, please select a different quarter.
-34.22%
Negative 5Y CAGR while WEED.TO stands at 37.06%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-9.09%
Negative 3Y CAGR while WEED.TO stands at 48.34%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
2504.48%
10Y OCF/share CAGR above 1.5x WEED.TO's 93.27%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
162.10%
5Y OCF/share CAGR above 1.5x WEED.TO's 66.39%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
185.89%
3Y OCF/share CAGR above 1.5x WEED.TO's 33.28%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-113.65%
Negative 10Y net income/share CAGR while WEED.TO is at 12.75%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-168.21%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-153.14%
Negative 3Y CAGR while WEED.TO is 2.72%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
9548.01%
Positive growth while WEED.TO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-27.53%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-56.57%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.57%
AR growth well above WEED.TO's 7.59%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.26%
Inventory growth well above WEED.TO's 6.19%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.91%
Positive asset growth while WEED.TO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.10%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-19.58%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
271.70%
R&D growth of 271.70% while WEED.TO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
36.61%
We expand SG&A while WEED.TO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.